We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
-2.6%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$7.35B
AUM Growth
-$159M
Cap. Flow
+$110M
Cap. Flow %
1.5%
Top 10 Hldgs %
34.24%
Holding
1,289
New
33
Increased
757
Reduced
419
Closed
47

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$7.26M
2
KVUE icon
Kenvue
KVUE
+$6.25M
3
BX icon
Blackstone
BX
+$6.2M
4
MSFT icon
Microsoft
MSFT
+$6.07M
5
MA icon
Mastercard
MA
+$5.73M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$4.58M
2
PH icon
Parker-Hannifin
PH
+$3.37M
3
MNST icon
Monster Beverage
MNST
+$2.91M
4
PAYX icon
Paychex
PAYX
+$2.36M
5
JNJ icon
Johnson & Johnson
JNJ
+$2.3M

Sector Composition

Rank Sector Weight
1 Technology 32.25%
2 Healthcare 12.54%
3 Consumer Discretionary 12.5%
4 Financials 10.64%
5 Communication Services 9.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AIT icon
1001
Applied Industrial Technologies
AIT
$12B
$354K ﹤0.01%
2,287
+12
+0.5% +$1.8K
ACIW icon
1002
ACI Worldwide
ACIW
$5.49B
$352K ﹤0.01%
15,600
-325
-2% -$7.6K
BCC icon
1003
Boise Cascade
BCC
$2.72B
$348K ﹤0.01%
3,374
-369
-10% -$38K
ICUI icon
1004
ICU Medical
ICUI
$4.38B
$345K ﹤0.01%
2,902
+439
+18% +$65.5K
TNET icon
1005
TriNet
TNET
$3.25B
$345K ﹤0.01%
2,965
-73
-2% -$7.7K
ATKR icon
1006
Atkore
ATKR
$3.16B
$344K ﹤0.01%
2,309
-41
-2% -$6.19K
ELF icon
1007
e.l.f. Beauty
ELF
$6.16B
$344K ﹤0.01%
3,135
+185
+6% +$22.5K
CRI icon
1008
Carter's
CRI
$1.24B
$341K ﹤0.01%
4,930
+354
+8% +$25.3K
RARE icon
1009
Ultragenyx Pharmaceutical
RARE
$2.54B
$339K ﹤0.01%
9,514
+53
+0.6% +$2.1K
BF.A icon
1010
Brown-Forman Class A
BF.A
$12.8B
$336K ﹤0.01%
5,789
+124
+2% +$8.41K
GO icon
1011
Grocery Outlet
GO
$1.21B
$336K ﹤0.01%
11,652
+776
+7% +$24.7K
XP icon
1012
XP
XP
$8.79B
$336K ﹤0.01%
14,578
+264
+2% +$6.62K
IBOC icon
1013
International Bancshares
IBOC
$4.4B
$334K ﹤0.01%
7,707
-55
-0.7% -$2.52K
PK icon
1014
Park Hotels & Resorts
PK
$3.19B
$334K ﹤0.01%
27,070
+433
+2% +$5.6K
RCM
1015
DELISTED
R1 RCM Inc. Common Stock
RCM
$331K ﹤0.01%
21,997
+4,814
+28% +$81K
CSTM icon
1016
Constellium
CSTM
$3.73B
$331K ﹤0.01%
18,201
-1,269
-7% -$22.4K
AYX
1017
DELISTED
Alteryx Inc
AYX
$327K ﹤0.01%
8,680
+470
+6% +$16.8K
IART icon
1018
Integra LifeSciences
IART
$1.33B
$325K ﹤0.01%
8,515
-180
-2% -$7.57K
AGNC icon
1019
AGNC Investment
AGNC
$13B
$323K ﹤0.01%
34,191
+14,304
+72% +$142K
APG icon
1020
APi Group
APG
$17.4B
$321K ﹤0.01%
18,560
+66
+0.4% +$1.21K
CXT icon
1021
Crane NXT
CXT
$2.88B
$319K ﹤0.01%
5,748
-101
-2% -$5.86K
ATI icon
1022
ATI
ATI
$28.9B
$317K ﹤0.01%
7,694
+101
+1% +$4.49K
ENOV icon
1023
Enovis
ENOV
$1.46B
$317K ﹤0.01%
6,003
+48
+0.8% +$2.8K
ENV
1024
DELISTED
ENVESTNET, INC.
ENV
$316K ﹤0.01%
7,180
-560
-7% -$30.8K
NSA
1025
DELISTED
National Storage Affiliates Trust
NSA
$316K ﹤0.01%
9,955
-179
-2% -$6.06K

Similar funds

Xponance's Q3 2023 Portfolio in Review

As of Q3 2023, Xponance held 1,289 positions worth $7.35B, down 2.1% from $7.51B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Xponance's Q3 2023 filing shows 33 new, 757 increased, 419 reduced and 47 closed positions. Its largest new stake was Kenvue: 270,037 shares worth $5.42M. The largest sale was Cigna, an estimated $4.58M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Xponance's largest Q3 2023 buy was Kenvue: 270,037 shares worth $5.42M.
  • Xponance added most to Apple in Q3 2023, an estimated $7.26M increase.
  • Xponance's biggest Q3 2023 reduction was Cigna, cutting an estimated $4.58M.
  • Xponance fully exited Life Storage, Inc. in Q3 2023, selling an estimated $1.38M.
  • Xponance's ten largest holdings make up 34% of its $7.35B portfolio in Q3 2023.
  • Xponance opened 33 new positions and closed 47 in Q3 2023.
  • Xponance's portfolio value fell 2.1% quarter-over-quarter to $7.35B.

Based on Xponance's 13F filing for Q3 2023, filed 24 Oct 2023.